SEC
Fundamental Analysis
76 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAGENiagen Bioscience, Inc. | 84.4 | 61.7 | 37 | 91 | +25.17% | +117.43% | n/a | +40.37% | -0.87% | 0% | 0 | n/a | 14.88x | Gross margin expansion, Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| AITXArtificial Intelligence Technology Solutions Inc. | 80 | 100 | 100 | 83 | +55.59% | n/a | n/a | +803.19% | -97.32% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Share count reduction1 warning |
| GDGENERAL DYNAMICS CORP | 67.8 | 51.3 | 55.5 | 87 | +22.19% | +14.52% | n/a | -0.51% | -1.35% | 1.87% | 48 | 38% | 21.59x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| GGenpact LTD | 64.9 | 50.1 | 50.1 | 87 | +9.55% | +18.23% | n/a | +5.23% | -4.49% | 1.69% | 10 | 21.31% | 9.91x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage |
| GNTXGENTEX CORP | 62.5 | 49.4 | 54.7 | 87 | +14.78% | +18.88% | n/a | -1.58% | -6.7% | 2.17% | 24 | 27.77% | 11.23x | Gross margin expansion, ROIC expansion, Share count reduction |
| CCCCCC Intelligent Solutions Holdings Inc. | 63.6 | 100 | 86 | 83 | +22.93% | +2.22% | n/a | +29.6% | -8.95% | 0% | 0 | n/a | 267.76x | Gross margin expansion, Operating leverage, ROIC expansion, Share count reduction1 warning |
| XGNEXAGEN INC. | 62.1 | 92.7 | 78.6 | 83 | +24.72% | -45.41% | n/a | +68.49% | +30.22% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction1 warning |
| GNRCGENERAC HOLDINGS INC. | 55.7 | 58.8 | 58.8 | 91 | +10.12% | +13.77% | n/a | -0.01% | -0.19% | 0% | 0 | 0.18% | 36.25x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage |
| GENGen Digital Inc. | 54.8 | 78.1 | 75.9 | 91 | +32.97% | +11.44% | n/a | -1.11% | -3.21% | 2.27% | 14 | 32.07% | 19.61x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| GENVRGen Digital Inc. | 54.8 | 78.1 | 75.9 | 91 | +32.97% | +11.44% | n/a | -1.11% | -3.21% | 0% | 0 | 32.07% | 0.72x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| REGNREGENERON PHARMACEUTICALS, INC. | 53 | 48.3 | 45.9 | 91 | +14.02% | +13.49% | n/a | -26.09% | -4.68% | 0.5% | 2 | 8.22% | n/a | Net debt reduction, Share count reduction1 warning |
| RGBPRegen BioPharma Inc | 60.5 | 0 | 0 | 79 | -0.13% | n/a | n/a | +249.93% | +2,755.78% | 0% | 0 | n/a | n/a | Net debt reduction3 warnings |
| RGBPPRegen BioPharma Inc | 60.5 | 0 | 0 | 79 | -0.13% | n/a | n/a | +249.93% | +2,755.78% | 0% | 0 | n/a | n/a | Net debt reduction3 warnings |
| BESSBimergen Energy Corp | 65 | n/a | n/a | 72 | +5,583.3% | n/a | n/a | n/a | -98.62% | 0% | 0 | n/a | n/a | Net debt reduction, Share count reduction1 warning |
| BESS-WTBimergen Energy Corp | 65 | n/a | n/a | 72 | +5,583.3% | n/a | n/a | n/a | -98.62% | 0% | 0 | n/a | n/a | Net debt reduction, Share count reduction1 warning |
| GCOGENESCO INC | 55.1 | 60.7 | 60.7 | 84 | +6.14% | n/a | n/a | -4.15% | +4.02% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| IPMINTELLIGENT PROTECTION MANAGEMENT CORP. | 50.5 | n/a | n/a | 89 | +198.9% | -23.92% | n/a | -6% | -1.19% | 0% | 0 | n/a | n/a | Net debt reduction, Share count reduction |
| BNGOBionano Genomics, Inc. | 54.6 | 100 | 100 | 82 | -0.39% | -89.92% | n/a | +366.43% | +328.58% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion2 warnings |
| DGDOLLAR GENERAL CORP | 52 | 53.5 | 53.5 | 86 | +6.65% | +25.33% | n/a | -4.93% | +0.62% | 1.98% | 12 | 34.35% | 15.6x | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage |
| URGNUroGen Pharma Ltd. | 64.9 | n/a | n/a | 68 | +85.13% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | Gross margin expansion3 warnings |
| WGSGeneDx Holdings Corp. | 57.3 | 32.2 | 32.2 | 77 | +46.88% | -29.93% | n/a | +268.61% | +5.55% | 0% | 0 | n/a | n/a | Gross margin expansion3 warnings |
| TXG10x Genomics, Inc. | 47.1 | 100 | 100 | 91 | +3.85% | -6.57% | n/a | +21.66% | +6.02% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| GNEGenie Energy Ltd. | 52.4 | 100 | 100 | 80 | +9.95% | n/a | n/a | n/a | -1.37% | 1.83% | 13 | 33.42% | n/a | Net debt reduction, Share count reduction1 warning |
| AMGNAMGEN INC | 45.8 | 100 | 100 | 91 | +15.15% | +16.35% | n/a | -6.72% | +0.55% | 2.47% | 16 | 66.45% | 24.8x | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage |
| GPCGENUINE PARTS CO | 51.2 | n/a | n/a | 79 | +6.97% | n/a | n/a | n/a | -0.88% | 3.32% | 44 | 855.02% | 19.57x | Gross margin expansion, Share count reduction |
1-25 of 76